Cardiovascular Risk Factors, Lipid Metabolism and Oxidative Stress
Relation Between Fatty Acids and Oxidative Stress Markers With Cardiovascular Risk Factors in a Healthy Population
1 other identifier
observational
500
1 country
2
Brief Summary
Cardiovascular diseases belong to the major causes of mortality in western populations, and atherosclerosis is the lesion responsible for clinical events, such as acute myocardial infarction and stroke. Atherosclerosis remains asymptomatic until a clinical event occurs, and in the pre-clinical stage it may be difficult to diagnose. As disease surrogate, a large number of risk factors for atherosclerosis are being recognized. Some of them are responsible for the epidemiologically very serious metabolic syndrome, which accounts for development of hyperlipidemia, obesity, diabetes or arterial hypertension. Health providers in continental diet-based countries suggest to embracing Mediterranean diet in order to contribute in reducing cardiovascular mortality. However, countries in the Mediterranean area are experiencing a shift in dietary habit towards continental diet with potential harmful change in mortality rates. Oxidative stress, including free radical-driven reactions and antioxidant status are considered important mediators to be considered in the diet-mediated effect on health. Important metabolic functions are also mediated by certain fatty acids. A comprehensive study of oxidative stress, including free radical-driven products and protective antioxidants, and fatty acids metabolism has never been reported in healthy subjects. In particular, high sensitive mass-spectrometry methods to study oxidative stress and fatty acids metabolism are rarely applied to epidemiological studies. The aim of the present grant project is therefore to assess in a large cross-sectional study the prevalence of oxidative stress markers, and fatty acids and to find any causal relation between these variables and metabolic syndrome. This population sample will be followed prospectively not only for time of the present grant project, but we would like to study metabolic variables with relation to the development of oxidative stress-mediated diseases, in particular those of cardiovascular system, on a longitudinal basis (prospective epidemiological study for at least 10 years). At same time we should be able to define the importance of individual markers of oxidative stress and fatty acids for early detection of these diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2009
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedFirst Submitted
Initial submission to the registry
September 30, 2010
CompletedFirst Posted
Study publicly available on registry
October 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedDecember 11, 2015
December 1, 2015
6.6 years
September 30, 2010
December 10, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fatty acids lipidomics and oxidative stress markers in healthy subjects
Assessment of plasma reference values of the complete fatty acid profile, oxysterols and alpha- and gamma-tocopherol in healthy italian subjects
21 months
Secondary Outcomes (2)
Prevalence of fatty acids levels, in a complete panel, and markers of oxidative stress in subjects with metabolic syndrome
21 months
Ten-year follow-up
ten years
Study Arms (1)
Blood donors
Evaluation of cardiovascular risk factors, oxidative stress and fatty acid metabolism in a cohort of blood donors
Eligibility Criteria
The study population consists of healthy blood donors
You may qualify if:
- Consecutive enrollment of blood donors
You may not qualify if:
- Subjects with known chronic disease, including cardiovascular disease, liver disease, kidney disease, neurodegenerative disease and cancer; autoimmune disease, endocrine system disease,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
AVIS
Latina, Latina, 04100, Italy
Vascular Medicine Unit, Department of Medical Science and Biotechnology
Latina, Latina, 04100, Italy
Biospecimen
Collection of plasma and serum samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Luigi Iuliano, M.D., Ph.D.
University of Roma La Sapienza
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
September 30, 2010
First Posted
October 1, 2010
Study Start
May 1, 2009
Primary Completion
December 1, 2015
Study Completion
December 1, 2021
Last Updated
December 11, 2015
Record last verified: 2015-12